| Financial Year |
March 31 2023 |
| Monetary Funds |
1,549,349,664.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
799,141,833.22 |
| Advances to Suppliers |
78,763,899.60 |
| Other Receivables |
57,373,892.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
279,902,263.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,883,373.42 |
| Total Current Assets |
2,890,657,754.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
47,088,492.59 |
| Long-term Equity Investment |
608,768.64 |
| Investment Properties |
-- |
| Fixed Assetes |
2,151,771,006.08 |
| Under-construction Projects |
457,775,865.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
85,814,658.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
129,616,258.23 |
| Deferred Income Tax Assets |
81,628,007.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,506,546,590.80 |
| Total Assets |
6,397,204,345.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
122,397,008.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,726,734.15 |
| Taxes Payable |
38,402,088.50 |
| Interest Payable |
-- |
| Dividend Payable |
8,673,361.29 |
| Other payables |
74,730,173.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
233,464,101.82 |
| Other Current Liabilities |
31,965,737.37 |
| Sub-Total of Current Liabilities |
595,203,495.51 |
| Long-term Loans |
239,116,738.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
668,316,438.08 |
| Total Liabilities |
1,263,519,933.59 |
| Paid-In Capital(Or Share Stock) |
775,770,137.00 |
| Capital Surplus |
1,944,819,050.37 |
| Surplus Reserve |
325,577,843.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,910,146,756.94 |
| Minority Stockholder's Interest |
145,405,142.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,988,279,268.83 |
| Owner's Equity（Stockholder's Equity） |
5,133,684,411.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,397,204,345.04 |
